The Newsweek magazine issue of November 17, 1997 featured "Impotency" as the cover story. In particular, three developmental-stage medications, each one a simple pill, were highlighted as having the potential to become "...the chemical cutting edge of the next sexual revolution." The three new drugs are briefly described below :
1. Viagra (sildenafil),
2. Vasomax (phentolamine), Zonagen
3. Spontane (apomorphine), TAP Pharmaceuticals, Inc.
USRF has from the onset been a study site for the U.S. clinical trials for Viagra. A number of our patients are currently in long-term open-label extensions of the early Viagra studies, and for the most part, our patients attest to the drug's safety and efficacy. At the present time (4th quarter, 1997), no new patients are being accepted into studies, pending FDA action.
*Note: At the time of this writing, Newsweek did not have a website. Reprints of the cover story, "The New Science of Impotence: Can It Be Cured with a Pill?," are available by phone at 1-212-445-4870.